Profile data is unavailable for this security.
About the company
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Diagnostics segment offers a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The GYN Surgical segment products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Fluent fluid management system and Acessa ProVu laparoscopic radiofrequency ablation system. The Skeletal Health segment products include Horizon DXA Systems and Fluoroscan Insight FD.
- Revenue in USD (TTM)3.96bn
- Net income in USD466.50m
- Incorporated1990
- Employees6.99k
- LocationHologic Inc250 Campus DriveMARLBOROUGH 1752United StatesUSA
- Phone+1 (508) 263-2900
- Fax+1 (302) 655-5049
- Websitehttps://www.hologic.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Globus Medical Inc | 1.90bn | 66.63m | 8.98bn | 5.00k | 105.22 | 2.29 | 35.99 | 4.73 | 0.632 | 0.632 | 15.48 | 29.04 | 0.5353 | 1.26 | 5.01 | 379,690.80 | 1.88 | 6.90 | 2.17 | 7.45 | 62.14 | 71.73 | 3.51 | 14.05 | 1.29 | -- | 0.0977 | 0.00 | 53.34 | 17.08 | -35.39 | -4.72 | 5.57 | -- |
| Henry Schein, Inc. | 12.45bn | 388.00m | 9.38bn | 25.00k | 24.76 | 2.61 | 14.17 | 0.7533 | 2.96 | 2.96 | 95.11 | 28.02 | 1.33 | 4.74 | 8.00 | 498,040.00 | 4.20 | 6.09 | 6.80 | 10.44 | 31.38 | 30.04 | 3.16 | 4.40 | 1.02 | 8.26 | 0.3207 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
| Teleflex Inc | 3.00bn | 296.02m | 10.03bn | 14.50k | 34.04 | 2.23 | 18.43 | 3.34 | 6.26 | 6.23 | 63.41 | 95.61 | 0.417 | 2.14 | 6.99 | 206,993.50 | 4.11 | 5.86 | 4.47 | 6.42 | 55.70 | 55.04 | 9.86 | 14.62 | 1.41 | 7.67 | 0.2808 | 15.84 | 6.57 | 3.97 | -1.47 | 12.73 | 2.51 | 0.00 |
| Shockwave Medical Inc | 787.97m | 163.50m | 12.38bn | 1.47k | 77.25 | 16.04 | 70.62 | 15.71 | 4.27 | 4.27 | 20.58 | 20.55 | 0.6493 | 1.05 | 7.55 | 536,763.60 | 13.47 | 10.29 | 14.91 | 11.39 | 86.99 | 84.69 | 20.75 | 15.14 | 12.61 | -- | 0.4936 | 0.00 | 49.11 | 126.45 | -31.81 | -- | 72.88 | -- |
| Insulet Corp | 1.78bn | 234.00m | 12.80bn | 3.00k | 56.91 | 16.19 | 41.51 | 7.19 | 3.21 | 3.21 | 23.61 | 11.29 | 0.7249 | 1.36 | 6.62 | 593,566.70 | 9.53 | 2.71 | 11.42 | 3.14 | 68.86 | 65.81 | 13.14 | 4.28 | 2.75 | 65.58 | 0.6393 | 0.00 | 30.02 | 24.66 | 4,384.78 | 128.77 | -7.63 | -- |
| Hologic Inc | 3.96bn | 466.50m | 17.40bn | 6.99k | 38.35 | 3.59 | 22.15 | 4.39 | 1.94 | 1.94 | 16.30 | 20.76 | 0.4361 | 2.66 | 5.82 | 566,609.40 | 5.14 | 11.40 | 5.74 | 13.38 | 55.12 | 60.29 | 11.78 | 20.95 | 3.29 | -- | 0.3465 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Baxter International Inc | 14.89bn | -38.00m | 17.56bn | 60.00k | -- | 2.15 | 14.06 | 1.18 | -0.0762 | 5.21 | 29.33 | 16.04 | 0.5311 | 3.21 | 5.71 | 248,200.00 | -0.107 | 0.1942 | -0.1338 | 0.2333 | 36.31 | 38.20 | -0.2015 | 0.3674 | 1.01 | 3.58 | 0.625 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Cooper Companies Inc | 3.67bn | 290.80m | 19.23bn | 15.00k | 97.78 | 2.50 | 28.89 | 5.25 | 0.9896 | 0.9896 | 7.36 | 38.73 | 0.3108 | 1.77 | 5.95 | 244,420.00 | 2.47 | 10.06 | 2.68 | 11.34 | 66.09 | 65.54 | 7.93 | 29.00 | 1.08 | 4.92 | 0.2649 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| Align Technology, Inc. | 3.92bn | 462.28m | 19.88bn | 21.61k | 43.49 | 5.29 | 33.03 | 5.07 | 6.07 | 6.07 | 51.44 | 49.94 | 0.6497 | 3.96 | 4.27 | 181,237.60 | 7.67 | 16.34 | 11.51 | 24.14 | 70.06 | 71.72 | 11.80 | 23.16 | 1.09 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Steris PLC | 5.44bn | 532.54m | 22.79bn | 17.00k | 42.95 | 3.61 | 28.07 | 4.19 | 5.37 | 3.81 | 54.85 | 63.91 | 0.4971 | 4.51 | 5.62 | -- | 4.88 | 4.03 | 5.32 | 4.41 | 43.23 | 43.50 | 9.82 | 8.20 | 2.34 | 8.76 | 0.3307 | 47.34 | 3.65 | 13.06 | 415.22 | 12.67 | 13.69 | 8.83 |
| Zimmer Biomet Holdings Inc | 7.45bn | 963.80m | 24.48bn | 18.00k | 25.76 | 1.94 | 12.73 | 3.29 | 4.62 | 4.62 | 35.72 | 61.24 | 0.3491 | 0.9052 | 5.27 | 414,027.80 | 4.52 | 2.21 | 5.14 | 2.52 | 71.89 | 71.25 | 12.95 | 7.28 | 0.802 | 7.32 | 0.315 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| West Pharmaceutical Services Inc. | 2.93bn | 568.70m | 24.55bn | 10.60k | 44.43 | 9.18 | 35.39 | 8.38 | 7.58 | 7.58 | 39.09 | 36.72 | 0.7995 | 4.20 | 5.65 | 276,283.00 | 15.08 | 15.61 | 17.99 | 18.65 | 37.15 | 38.06 | 18.86 | 18.47 | 1.95 | -- | 0.0714 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
Data as of May 22 2024. Currency figures normalised to Hologic Inc's reporting currency: US Dollar USD
42.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 25.78m | 10.98% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 22.35m | 9.52% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 14.23m | 6.06% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 10.47m | 4.46% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 2024 | 5.96m | 2.54% |
| Victory Capital Management, Inc. (Investment Management)as of 31 Mar 2024 | 5.70m | 2.43% |
| Geode Capital Management LLCas of 31 Mar 2024 | 5.53m | 2.36% |
| Macquarie Investment Management Business Trustas of 31 Mar 2024 | 4.11m | 1.75% |
| Columbia Management Investment Advisers LLCas of 31 Mar 2024 | 3.39m | 1.45% |
| BlackRock Investment Management (UK) Ltd.as of 31 Mar 2024 | 3.12m | 1.33% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
